Ophthalmic Viscoelastic Devices Market to Witness Exponential Growth by 2027

Page 1

Ophthalmic Viscoelastic Devices Market: Overview Ophthalmic viscoelastic devices or OVDs are primarily used by ophthalmologists to perform different eye surgeries such as glaucoma or cataract surgery. These devices help in protecting the fragile ocular structure along with generating proper pressure in the anterior chamber. Read Report Overview - https://www.transparencymarketresearch.com/ophthalmic-viscoelasticdevices-market.html These devices also help in creating precise compartmentalization of the eye during surgery, which ultimately results in faster and safer surgery. This also helps in swift recovery of the patients. The ophthalmologists use different types of ophthalmic devices as per their requirement. Thus, ophthalmic viscoelastic devices play a major role in the treating wide range of eye ailments or disorders during the surgery across the world. The report on the global ophthalmic viscoelastic devices market offers meaningful insights and information for the forecast period of 2019 to 2027. This report tries to map all the important trends, drivers, technologies, and developments that are influencing the growth of the ophthalmic viscoelastic devices market. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=70557 Global Ophthalmic Viscoelastic Devices Market: Notable Developments Some of the recent notable developments in the global ophthalmic viscoelastic devices are given below: In July 2019, Bausch + Lomb, an international leader in global eye health market and completely owned subsidiary of Bausch Health Companies Inc., announced the launch of their new product in the US. The product is called Ocuvite® Eye Performance Vitamins. The product is a nutritional supplement created to meet the evolving needs of the customers while helping the company to enhance its existing business portfolio. Bohus Biotech have recently launched a new product line in their ophthalmic viscoelastic devices segment. The products are named Microvisc, Microvisc Plus, and Microvisc Phaco. These products are widely used as surgical aids in refractive and cataract surgeries. Microvisc OVDs are produced from hyaluronic acid that naturally has a high molecular structure. This acid derived from a natural biological source. In 2016 Carl Zeiss Meditech AG appointed Andrew Ihan Chang to lead the global sales for ophthalmic devices. He was put in charge of its international sales organization for the recently consolidated strategic business unit global ophthalmic device. Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php? flag=CR&rep_id=70557 Cima Technology Inc. have recently announced to launch a new product CIMblu. This product is a dye that will be used in cataract surgery to stain the anterior capsule.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.